These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23600140)
1. [Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method]. He Y; Wang JS; Zhang P; Zhang WJ; Huang QL; Hua ZC Yao Xue Xue Bao; 2013 Jan; 48(1):45-51. PubMed ID: 23600140 [TBL] [Abstract][Full Text] [Related]
2. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC]. Yang J; Chen SZ Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302 [TBL] [Abstract][Full Text] [Related]
3. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer. Zhu K; Fang W; Chen Y; Lin S; Chen X Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445 [TBL] [Abstract][Full Text] [Related]
4. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1. Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625 [TBL] [Abstract][Full Text] [Related]
5. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. Azijli K; van Roosmalen IA; Smit J; Pillai S; Fukushima M; de Jong S; Peters GJ; Bijnsdorp IV; Kruyt FA Cancer Chemother Pharmacol; 2014 Jun; 73(6):1273-83. PubMed ID: 24744163 [TBL] [Abstract][Full Text] [Related]
6. Phytosphingosine in combination with TRAIL sensitizes cancer cells to TRAIL through synergistic up-regulation of DR4 and DR5. Choi SY; Kim MJ; Chung HY; Lee SJ; Jang YJ Oncol Rep; 2007 Jan; 17(1):175-84. PubMed ID: 17143496 [TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471 [TBL] [Abstract][Full Text] [Related]
8. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
9. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Jiang L; Hao JL; Jin ML; Zhang YG; Wei P Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635 [TBL] [Abstract][Full Text] [Related]
10. [Growth inhibition of combined pathway inhibitors on KRAS mutated non-small cell lung cancer cell line]. Li ZW; Yang ZL; Feng HL; Bian XC; Liu YY; Liu YQ Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):330-5. PubMed ID: 24004591 [TBL] [Abstract][Full Text] [Related]
11. Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. Gatti L; Cossa G; Tinelli S; Carenini N; Arrighetti N; Pennati M; Cominetti D; De Cesare M; Zunino F; Zaffaroni N; Perego P J Pharmacol Exp Ther; 2014 Mar; 348(3):360-71. PubMed ID: 24345465 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand. Fang F; Wang AP; Yang SF Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761 [TBL] [Abstract][Full Text] [Related]
13. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
14. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft. Kong M; Fan J; Dong A; Cheng H; Xu R Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038 [TBL] [Abstract][Full Text] [Related]
15. Effects of CAY10404 on the PKB/Akt and MAPK pathway and apoptosis in non-small cell lung cancer cells. Cho Y; Park MJ; Park M; Min SS; Yee J; Kim C; Han MS; Han SH Respirology; 2009 Aug; 14(6):850-8. PubMed ID: 19703066 [TBL] [Abstract][Full Text] [Related]
16. Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. Lan Y; Liu X; Zhang R; Wang K; Wang Y; Hua ZC Biometals; 2013 Apr; 26(2):241-54. PubMed ID: 23378009 [TBL] [Abstract][Full Text] [Related]
17. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells. Lepage C; Léger DY; Bertrand J; Martin F; Beneytout JL; Liagre B Cancer Lett; 2011 Feb; 301(2):193-202. PubMed ID: 21195543 [TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells. Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158 [TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
20. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]